Depression, anxiety and stress during the COVID-19 pandemic: results from a New Zealand cohort study on mental well-being.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
03 05 2021
Historique:
entrez: 4 5 2021
pubmed: 5 5 2021
medline: 13 5 2021
Statut: epublish

Résumé

The COVID-19 pandemic has caused unprecedented disruption to daily life. This study investigated depression, anxiety and stress in New Zealand (NZ) during the first 10 weeks of the COVID-19 pandemic, and associated psychological and behavioural factors. It also compares the results with a similar cross-sectional study in the UK. Cross-sectional study. NZ community cohort. N=681 adults (≥18 years) in NZ. The cohort was predominantly female (89%) with a mean age of 42 years (range 18-87). Most (74%) identified as NZ European and almost half (46%) were keyworkers. Most were non-smokers (95%) and 20% identified themselves as having clinical risk factors which would put them at increased or greatest risk of COVID-19. Depression, anxiety, stress, positive mood and engagement in health behaviours (smoking, exercise, alcohol consumption). Depression and anxiety significantly exceeded population norms (p<0.0001). Being younger (p<0.0001) and most at risk of COVID-19 (p<0.05) were associated with greater depression, anxiety and stress. Greater positive mood, lower loneliness and greater exercise were protective factors for all outcomes (p<0.0001). Smoking (p=0.037) and alcohol consumption (p<0.05) were associated with increased anxiety. Pet ownership was associated with lower depression (p=0.006) and anxiety (p=0.008). When adjusting for age and gender differences, anxiety (p The NZ population had higher depression and anxiety compared with population norms. Younger people and those most at risk of COVID-19 reported poorer mental health. Interventions should promote frequent exercise, and reduce loneliness and unhealthy behaviours.

Identifiants

pubmed: 33941630
pii: bmjopen-2020-045325
doi: 10.1136/bmjopen-2020-045325
pmc: PMC8098295
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e045325

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Sci Rep. 2020 Jun 16;10(1):9740
pubmed: 32546704
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Clinics (Sao Paulo). 2005 Feb;60(1):61-70
pubmed: 15838583
Lancet Psychiatry. 2020 Apr;7(4):e17-e18
pubmed: 32085841
Aust N Z J Psychiatry. 2020 Oct;54(10):1044
pubmed: 32615791
Psychol Med. 2012 Apr;42(4):829-42
pubmed: 21896237
J Epidemiol Community Health. 2005 Aug;59(8):619-27
pubmed: 16020636
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Br J Psychiatry. 2010 Jun;196(6):440-6
pubmed: 20513853
Front Psychol. 2020 Sep 11;11:565153
pubmed: 33041928
Psychiatry Res. 2020 May;287:112934
pubmed: 32229390
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
J Affect Disord. 2009 Jun;115(3):367-75
pubmed: 19004504
Public Health. 2017 Nov;152:157-171
pubmed: 28915435
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Br J Health Psychol. 2003 Feb;8(Pt 1):107-22
pubmed: 12643820
Am J Community Psychol. 2007 Dec;40(3-4):313-32
pubmed: 17906927
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Psychosom Med. 2002 Sep-Oct;64(5):727-39
pubmed: 12271103
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
Epidemiol Health. 2016 Nov 5;38:e2016048
pubmed: 28196409
Lancet. 2020 Feb 22;395(10224):e37-e38
pubmed: 32043982
BMJ Open. 2020 Sep 15;10(9):e040620
pubmed: 32933965
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Affect Disord. 2020 Dec 1;277:379-391
pubmed: 32861839
Aust N Z J Psychiatry. 2020 Dec 10;:4867420976856
pubmed: 33300367
Psychol Rep. 2005 Jun;96(3 Pt 1):713-29
pubmed: 16050629
J Health Psychol. 2013 Dec;18(12):1617-28
pubmed: 24155195
Aust N Z J Psychiatry. 2020 Jul;54(7):759
pubmed: 32375506
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
J Psychiatr Ment Health Nurs. 2004 Aug;11(4):476-83
pubmed: 15255923
Br J Psychiatry. 2010 Jun;196(6):425-6
pubmed: 20513848
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Front Psychiatry. 2020 Sep 09;11:569981
pubmed: 33033485
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Front Psychiatry. 2020 May 06;11:378
pubmed: 32477179
J Pers Soc Psychol. 1984 Nov;47(5):1105-17
pubmed: 6520704
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
Psychiatry Res. 2020 Jun;288:112992
pubmed: 32302816
Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):551-5
pubmed: 23664569
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Kaohsiung J Med Sci. 1998 Nov;14(11):717-26
pubmed: 9838768

Auteurs

Norina Gasteiger (N)

Psychological Medicine, The University of Auckland, Auckland, New Zealand.

Kavita Vedhara (K)

Division of Primary Care, University of Nottingham, Nottingham, UK.

Adam Massey (A)

Division of Primary Care, University of Nottingham, Nottingham, UK.

Ru Jia (R)

Division of Primary Care, University of Nottingham, Nottingham, UK.

Kieran Ayling (K)

Division of Primary Care, University of Nottingham, Nottingham, UK.

Trudie Chalder (T)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Carol Coupland (C)

Division of Primary Care, University of Nottingham, Nottingham, UK.

Elizabeth Broadbent (E)

Psychological Medicine, The University of Auckland, Auckland, New Zealand e.broadbent@auckland.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH